Novartis' CEO warned Tuesday that U.S. drug pricing policy under President Donald Trump poses a "very difficult situation." ...

On Tuesday, Novartis NVS CEO Vas Narasimhan said the Trump administration's "most favored nation" (MFN) drug pricing policy ...

Supervised consumption sites have become a flashpoint in the debate over how to address the opioid crisis, often framed in ...

Katherine Harris with the Baker Institute at Rice University tracks the hemp industry in Texas. She says a more nuanced ...

San Francisco is moving to upend decades of widely accepted, research-based policy on housing and substance use—and other ...

Most Favored Nation (MFN) drug pricing is just price controls by another name. Instead of openly capping what a drug can cost ...

The Trump administration, in a stark departure from the "Just Say No" era, is funding psychedelics research and rescheduling ...

Americans pay 278% more for same medications going to people in other countries. Executive Order ending this must be codified ...

Regrets about America’s drug policies in recent years keep piling up. An article in The Wall Street Journal this week noted the proliferation of cannabis in schools since legalization began. “It’s ...

Progressive “harm reduction” advocates have insisted for decades that active users should take a central role in crafting drug policy. While this belief is profoundly reckless—akin to letting drunk ...

The National Drug Council (CND) of the Dominican Republic signed an inter-institutional cooperation agreement with the ...